Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001059253 | SCV001223873 | likely pathogenic | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 3 of the PCARE protein (p.Cys3Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 33576794, 34964967; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 854244). |
Blueprint Genetics | RCV001074612 | SCV001240203 | uncertain significance | Retinal dystrophy | 2019-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002482039 | SCV002790149 | uncertain significance | Retinitis pigmentosa 54 | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001074612 | SCV004705378 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |